Heartflow (NASDAQ:HTFL) Shares Down 7.7% After Insider Selling

Heartflow, Inc. (NASDAQ:HTFL) shares traded down 7.7% on Friday after an insider sold shares in the company. The stock traded as low as $22.69 and last traded at $22.95. 298,364 shares traded hands during trading, a decline of 79% from the average session volume of 1,415,499 shares. The stock had previously closed at $24.86.

Specifically, Director Julie A. Cullivan sold 9,122 shares of Heartflow stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $25.00, for a total value of $228,050.00. Following the sale, the director owned 27,291 shares of the company’s stock, valued at $682,275. The trade was a 25.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Analyst Ratings Changes

Several research firms recently commented on HTFL. Wells Fargo & Company began coverage on Heartflow in a report on Wednesday, January 28th. They set an “overweight” rating and a $38.00 price target on the stock. Weiss Ratings reiterated a “sell (d)” rating on shares of Heartflow in a research report on Monday, December 29th. JPMorgan Chase & Co. raised their target price on shares of Heartflow from $36.00 to $40.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Stifel Nicolaus lifted their price target on shares of Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. Finally, Canaccord Genuity Group upped their price target on shares of Heartflow from $39.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, November 13th. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Heartflow currently has a consensus rating of “Moderate Buy” and an average price target of $38.50.

Heartflow Stock Performance

The stock has a market capitalization of $1.96 billion and a PE ratio of -12.70. The business has a 50 day moving average of $28.43 and a two-hundred day moving average of $30.96.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Caitong International Asset Management Co. Ltd acquired a new position in shares of Heartflow during the fourth quarter valued at about $27,000. TFC Financial Management Inc. acquired a new stake in Heartflow in the 3rd quarter worth approximately $40,000. Russell Investments Group Ltd. purchased a new stake in Heartflow during the 4th quarter worth approximately $45,000. Legal & General Group Plc purchased a new stake in Heartflow during the 3rd quarter worth approximately $59,000. Finally, Strs Ohio acquired a new position in Heartflow during the 4th quarter valued at approximately $99,000.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.